Historical record - last NADAC publication: 5/20/2015
Product Information
IRBESARTAN 300 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3358 per EA under NDC 65862063990. Its NADAC has been published 78 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862063990
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/20/2015
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA203081On Market Since
9/27/2012
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 300 MG TABLET has been published 78 times since Nov 28, 2013, and over the history we have for it it has declined 4.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3358 per EA |
|---|---|
| All-time high | $0.3709 (Mar 12, 2014) |
| All-time low | $0.3088 (Jan 21, 2015) |
| Median price | $0.3431 |
| Average price | $0.3420 |
| Largest weekly change | +13.7% (Feb 18, 2015) |
| Weeks tracked | 78 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 54% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IRBESARTAN 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 300 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.3358 per EA (NDC 65862063990), effective May 20, 2015.
How has the price of IRBESARTAN 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 300 MG TABLET has declined 4.2%. It has been tracked across 78 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 300 MG TABLET?
Since Nov 28, 2013, the NADAC for IRBESARTAN 300 MG TABLET has ranged from a low of $0.3088 (Jan 21, 2015) to a high of $0.3709 (Mar 12, 2014), with a median of $0.3431 per EA.
Are there cheaper alternatives to IRBESARTAN 300 MG TABLET?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IRBESARTAN 300 MG TABLET, is $0.1530 per EA — about 54% below IRBESARTAN 300 MG TABLET.
Who manufactures IRBESARTAN 300 MG TABLET?
IRBESARTAN 300 MG TABLET (NDC 65862063990) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification